Presence of a significant medical or psychiatric condition (Examples include: Diagnosis and treatment of tuberculosis (TB) or HIV; renal insufficiency; hepatic disease; oral or parenteral medication known to affect the immune function, such as corticosteroids, other immunosuppressant drugs; or behavioural or memory issues)
Ever having received oral cholera vaccine.
Receipt of an investigational product (within 30 days before vaccination).
History of diarrhoea in 7 days prior to first dose of vaccine (defined as =3 unformed loose stools in 24 hours).
History of chronic diarrhea (lasting for more than 2 weeks in the past 6 months)
Current use of laxatives, antacids, or other agents to lower stomach acidity?
Planning to become pregnant in the next 2 years.

NCT03373669_exc_T1
Condition
psychiatric condition
NCT03373669_exc_T2
Condition
medical condition
NCT03373669_exc_T3
Qualifier
significant
NCT03373669_exc_T4
Scope
medical or psychiatric condition
NCT03373669_exc_T5
Condition
tuberculosis (TB)
NCT03373669_exc_T6
Condition
HIV
NCT03373669_exc_T7
Procedure
treatment
NCT03373669_exc_T8
Condition
renal insufficiency
NCT03373669_exc_T9
Condition
hepatic disease
NCT03373669_exc_T10
Drug
parenteral medication
NCT03373669_exc_T11
Drug
oral medication
NCT03373669_exc_T12
Qualifier
known to affect the immune function
NCT03373669_exc_T13
Scope
oral or parenteral medication
NCT03373669_exc_T14
Drug
corticosteroids
NCT03373669_exc_T15
Drug
immunosuppressant drugs
NCT03373669_exc_T16
Qualifier
other
NCT03373669_exc_T17
Condition
behavioural issues
NCT03373669_exc_T18
Condition
memory issues
NCT03373669_exc_T19
Scope
behavioural or memory issues
NCT03373669_exc_T20
Scope
corticosteroids, other immunosuppressant drugs; or behavioural or memory issues
NCT03373669_exc_T21
Scope
oral or parenteral medication known to affect the immune function
NCT03373669_exc_T22
Scope
treatment of tuberculosis (TB) or HIV; renal insufficiency; hepatic disease; oral or parenteral medication known to affect the immune function, such as corticosteroids, other immunosuppressant drugs; or behavioural or memory issues
NCT03373669_exc_T23
Drug
oral cholera vaccine
NCT03373669_exc_T25
Condition
diarrhoea
NCT03373669_exc_T26
Temporal
in 7 days prior to first dose of vaccine
NCT03373669_exc_T27
Reference_point
first dose of vaccine
NCT03373669_exc_T28
Value
=3
NCT03373669_exc_T29
Measurement
unformed loose stools in 24 hours
NCT03373669_exc_T30
Condition
chronic diarrhea
NCT03373669_exc_T31
Observation
History
NCT03373669_exc_T32
Observation
History
NCT03373669_exc_T33
Multiplier
lasting for more than 2 weeks
NCT03373669_exc_T34
Temporal
in the past 6 months
NCT03373669_exc_T35
Drug
laxatives
NCT03373669_exc_T36
Drug
antacids
NCT03373669_exc_T37
Drug
agents to lower stomach acidity
NCT03373669_exc_T38
Qualifier
other